Current Suspected Overdose Deaths in Delaware for 2021: Get Help Now!
New opportunity to participate in an expert-led, interactive training while continuing to practice
DMMA is offering specialized training to equip participants with the knowledge and skills to treat opioid use disorder through self-paced modules, live discussions, and facilitated webinars, through funding from the Center for Medicare and Medicaid Services (CMS).
This initiative will train prescribers and practice managers to prescribe buprenorphine to treat OUD in primary care and other outpatient settings. Click here to learn more about the use of buprenorphine as an effective and evidence-based treatment for OUD."
|Clinical Track||Practice Implementation Track|
|For physicians, nurse practitioners, and physician assistants, to build knowledge and skills for effectively assessing and treating OUD in the outpatient setting.||For practice managers and clinical staff who advance operational and administrative aspects of their OBOT program, to provide guidance for developing effective workflows and infrastructure.|
Delaware’s Division of Substance Abuse and Mental Health is also offering up to $49,000 for practices represented in the OBOT Fellowship that agree to implement OBOT and meet specific performance metrics.
The Fellowship is full. Registration is closed. If you are interested in learning about related opportunities, contact us via email at SUPPORTAct@delaware.gov
Listen to this presentation to learn more about the Delaware Office-Based Opioid Treatment Fellowship
Download this flyer for a summary to share the training information with others.
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $3,579,864 with 100 percent funded by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/HHS, or the U.S. Government.